CSIMarket Company Name, Ticker, Industry, else..


Dermata Therapeutics Inc   (DRMA)
Other Ticker:  
 


 

Dermata Therapeutics Inc

DRMA's Financial Statements and Analysis



Dermata Therapeutics Inc reported IV. Quarter net loss per share of $-0.15 compare to earnings per share of $0.93 in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.


IV. Quarter
Earnings Per Share Revenues
$ -0.15 $  0 Mill
$-1.08     Unch.    



Dermata Therapeutics Inc 's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.


Dermata Therapeutics Inc is Expected to report next financial results on May 15, 2023.

More on DRMA's Income Statement



Dermata Therapeutics Inc 's in IV. Quarter recorded net loss of $-1.670 million, compare to net income of $3.314 million achieved in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-2.425 million realized in previous quarter.

More on DRMA's Growth

Dermata Therapeutics Inc Inventories
In IV. Quarter company's net cash and cash equivalents decreased by $-2 million


Dermata Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Dermata Therapeutics Inc payed $ -0.80 cash per share, on a free-cash flow basis .